Patent details

Basic Information

Publication number:

EP1532127

PCT Application Number:

PCT/US/2003/020094

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP037620549

PCT Publication Number:

WO/2004/002975

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PREPARATION OF STEREOISOMERS OF (3ALPHA, 3ALPHA/BETA, 6ALPHA/BETA) HEXAHYDROFURO(2,3-b) FURAN-3-OL

French Title of Invention:

PREPARATION DE STEREOISOMERES DE (3ALPHA, 3ALPHA/BETA, 6ALPHA/BETA) HEXAHYDROFURO(2,3-b) FURAN-3-OL

German Title of Invention:

HERSTELLUNG VON STEREOISOMEREN VON (3ALPHA, 3ALPHA/BETA, 6ALPHA/BETA)HEXAHYDROFUROê2,3-bëFURAN-3-OL

SPC Number:

Dates

Filing date:

25/06/2003

Grant date:

27/09/2006

EP Publication Date:

27/09/2006

PCT Publication Date:

08/01/2004

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

25/05/2005

EP B1 Publication Date:

27/09/2006

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

25/06/2009

Expiration date:

25/06/2023

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

25/06/2003

 

 

Name:

SMITHKLINE BEECHAM CORPORATION

Address:

One Franklin Plaza P.O. Box 7929, Philadelphia, PA 19101, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

04/10/2006

Address:

PO Box 48, 8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

PATTERSON Daniel, Edward GlaxoSmithKline

Address:

United States (US)

2

Name:

DOAN Brian, Daniel GlaxoSmithKline

Address:

United States (US)

3

Name:

ROBERTS John, C. GlaxoSmithKline

Address:

United States (US)

Priority

Priority Number:

392677 P

Priority Date:

27/06/2002

Priority Country:

United States (US)

Classification

Main IPC Class:

C07D 307/26;

Filing date	Document type	Number of pages